Literature DB >> 32815118

Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia.

S Woelke1, R Schrewe1, H Donath1, M Theis2, M Kieslich2, R Duecker1, G Auburger3, R Schubert3, S Zielen4.   

Abstract

Ataxia telangiectasia (A-T) is a devastating multi-system disorder characterized by progressive cerebellar ataxia and immunodeficiency. The neurological decline may be caused by multiple factors of which ongoing inflammation and oxidative stress may play a dominant role. The objective of the present investigation was to determine cerebrospinal fluid (CSF) proteins and possible low-grade inflammation and its relation to age and neurological deterioration. In the present study, we investigated 15 patients with A-T from 2 to 16 years. Our investigation included blood and CSF tests, clinical neurological examination, A-T score, and MRI findings. The albumin ratio (AR) was analyzed to determine the blood-brain-barrier function. In addition, inflammatory cytokines (IL-1α, IL-6, IL-8, IL-12 p40, IL-17A, IFN-γ, TNF-α) were measured by the multiplex cytometric bead array. We compared the results with those from an age-matched control group. Three of the A-T patients were analyzed separately (one after resection of a cerebral meningioma, one after radiation and chemotherapy due to leukemia, one after stem cell transplantation). Patient had significantly more moderate and severe side effects due to CSF puncture (vomiting, headache, need for anti-emetic drugs) compared with healthy controls. Total protein, albumin, and the AR increased with age indicating a disturbed blood barrier function in older children. There were no differences for cytokines in serum and CSF with the exception of IL-2, which was significantly higher in controls in serum. The AR is significantly altered in A-T patients, but low-grade inflammation is not detectable in serum and CSF.

Entities:  

Keywords:  Albumin ratio; Ataxia score; Ataxia telangiectasia; Cerebrospinal fluid; Cytokines; Neurodegeneration

Year:  2021        PMID: 32815118     DOI: 10.1007/s12311-020-01175-x

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  46 in total

1.  Elevated serum IL-8 levels in ataxia telangiectasia.

Authors:  Sharon A McGrath-Morrow; J Michael Collaco; Thomas O Crawford; Kathryn A Carson; Maureen A Lefton-Greif; Pamela Zeitlin; Howard M Lederman
Journal:  J Pediatr       Date:  2010-02-20       Impact factor: 4.406

2.  Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia.

Authors:  Sandra Voss; Julia Pietzner; Franziska Hoche; Alexander Malcolm R Taylor; James I Last; Ralf Schubert; Stefan Zielen
Journal:  Growth Factors       Date:  2014-06       Impact factor: 2.511

3.  Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.

Authors:  Romain Micol; Lilia Ben Slama; Felipe Suarez; Loïc Le Mignot; Julien Beauté; Nizar Mahlaoui; Catherine Dubois d'Enghien; Anthony Laugé; Janet Hall; Jérôme Couturier; Louis Vallée; Bruno Delobel; François Rivier; Karine Nguyen; Thierry Billette de Villemeur; Jean-Louis Stephan; Pierre Bordigoni; Yves Bertrand; Nathalie Aladjidi; Jean-Michel Pedespan; Caroline Thomas; Isabelle Pellier; Michel Koenig; Olivier Hermine; Capucine Picard; Despina Moshous; Bénédicte Neven; Fanny Lanternier; Stéphane Blanche; Marc Tardieu; Marianne Debré; Alain Fischer; Dominique Stoppa-Lyonnet
Journal:  J Allergy Clin Immunol       Date:  2011-06-12       Impact factor: 10.793

Review 4.  Neurodegeneration in ataxia telangiectasia: what is new? What is evident?

Authors:  Franziska Hoche; Kay Seidel; Marius Theis; Stefan Vlaho; Ralf Schubert; Stefan Zielen; Matthias Kieslich
Journal:  Neuropediatrics       Date:  2012-05-21       Impact factor: 1.947

5.  Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs.

Authors:  C Barlow; P A Dennery; M K Shigenaga; M A Smith; J D Morrow; L J Roberts; A Wynshaw-Boris; R L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 6.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

7.  Infections of the respiratory system in patients with ataxia-telangiectasia.

Authors:  Scott A Schroeder; Stefan Zielen
Journal:  Pediatr Pulmonol       Date:  2013-06-13

8.  Elevated oxidative stress in patients with ataxia telangiectasia.

Authors:  Janine Reichenbach; Ralf Schubert; Detlef Schindler; Klaus Müller; Hansjosef Böhles; Stefan Zielen
Journal:  Antioxid Redox Signal       Date:  2002-06       Impact factor: 8.401

Review 9.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

10.  The interaction of the atm genotype with inflammation and oxidative stress.

Authors:  Yan Yang; Chin Wai Hui; Jiali Li; Karl Herrup
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more
  2 in total

1.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

2.  Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia.

Authors:  H Donath; S Woelke; R Schubert; M Kieslich; M Theis; G Auburger; R P Duecker; S Zielen
Journal:  Cerebellum       Date:  2021-04-24       Impact factor: 3.847

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.